Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2023; 22: 177-185
Эпителиальные злокачественные опухоли околоушных слюнных желез у детей и подростков
https://doi.org/10.24287/1726-1708-2023-22-4-177-185Аннотация
В статье представлены данные об эпителиальных злокачественных опухолях околоушных слюнных желез у детей и подростков. Приведены историческая справка и современная классификация, предложенная Всемирной организацией здравоохранения в 2022 г. Представлена эволюция методов хирургического и нехирургического лечения, применяемых в детской онкологии.
Список литературы
1. Ethunandan M., Ethunandan A., Macpherson D.W., Conroy B., Pratt C. Parotid neoplasms in children: experience of diagnosis and management in a district general hospital. Int J Oral Maxillofac Surg 2003; 32 (4): 373–7.
2. De Ribeiro K.C.B., Kowalski L.P., Saba L.M.B., De Camargo B. Epithelial salivary glands neoplasms in children and adolescents: a fortyfour-year experience. Med Pediatr Oncol 2002; 39 (6): 594–600.
3. Yoshida E.J., García J., Eisele D.W., Chen A.M. Salivary gland malignancies in children. Int J Pediatr Otorhinolaryngol 2014; 78 (2): 174–8.
4. Zamani M., Grønhøj C., Schmidt Jensen J., von Buchwald C., Charabi B.W., Hjuler T. Survival and characteristics of pediatric salivary gland cancer: A systematic review and meta-analysis. Pediatr Blood Cancer 2019; 66 (3): e27543. DOI: 10.1002/pbc.27543
5. Jensen J.S., Grønhøj C., Garset-Zamani M., Westergaard-Nielsen M., Bjørndal K., Kiss K., et al. Incidence and survival of salivary gland cancer in children and young adults in Denmark: A nation-wide study for the period 1990–2015. Int J Pediatr Otorhinolaryngol 2021; 143: 110637. DOI: 10.1016/j.ijporl.2021.110637
6. Ullah A., Khan J., Waheed A., Karki N.R., Goodbee M., Yasinzai A.Q.K., et al. Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management. Cancers (Basel) 2023; 15 (1): 250. DOI: 10.3390/cancers15010250
7. Geiger J.L., Ismaila N., Beadle B., Caudell J.J., Chau N., Deschler D., et al. Management of Salivary Gland Malignancy: ASCO Guideline. J Clin Oncol 2021; 39 (17): 1909–41.
8. Surun A., Schneider D.T., Ferrari A., Stachowicz-Stencel T., Rascon J., Synakiewicz A., et al. Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations. Pediatr Blood Cancer 2021; 68 (S4). DOI: 10.1002/pbc.29058
9. [Electronic resource] BlueBooksOnline. URL: https://tumourclassification.iarc.who.int/chaptercontent/52/53 (accessed 07.10.2023).
10. Seifert G., Brocheriou C., Cardesa A., Eveson J.W. WHO International Histological Classification of Tumours Tentative Histological Classification of Salivary Gland Tumours. Pathol Res Pract 1990; 186 (5): 555–81.
11. Skálová A., Hyrcza M.D., Leivo I. Update from the 5th Ed. of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands. Head Neck Pathol 2022; 16 (1): 40–53.
12. [Electronic resource] IARC Publications Website – Paediatric Tumours. URL: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Paediatric-Tumours-2023 (accessed 06.10.2023).
13. Aro K., Leivo I., Mäkitie A. Management of salivary gland malignancies in the pediatric population. Curr Opin Otolaryngol Head Neck Surg 2014; 22 (2): 116–20.
14. Sultan I., Rodriguez-Galindo C., Al-Sharabati S., Guzzo M., Casanova M., Ferrari A. Salivary gland carcinomas in children and adolescents: A population-based study, with comparison to adult cases. Head Neck 2011; 33 (10): 1476–81.
15. Laikui L., Hongwei L., Hongbing J., Zhixiu H. Epithelial salivary gland tumors of children and adolescents in west China population: a clinicopathologic study of 79 cases. J Oral Pathol Med 2008; 37 (4): 201–5.
16. Liu B., Liu J.Y., Zhang W.F., Jia J. Pediatric parotid tumors: Clinical review of 24 cases in a Chinese population. Int J Pediatr Otorhinolaryngol 2012; 76 (7): 1007–11.
17. Lennon P., Silvera V.M., Perez-Atayde A., Cunningham M.J., Rahbar R. Disorders and Tumors of the Salivary Glands in Children. Otolaryngol Clin North Am 2015; 48 (1): 153–73.
18. Rzepakowska A., Osuch-Wójcikiewicz E., Sobol M., Cruz R., Sielska-Badurek E., Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Otorhinolaryngol 2017; 274 (8): 3231–40.
19. Zheng M., Plonowska K.A., Strohl M.P., Ryan W.R. Surgeon-performed ultrasound for the assessment of parotid masses. Am J Otolaryngol 2018; 39 (5): 467–71.
20. Mitani Y., Liu B., Rao P.H., Borra V.J., Zafereo M., Weber R.S., et al. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res 2016; 22 (3): 725–33.
21. Liu Y., Li J., Tan Y.R., Xiong P., Zhong L.P. Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119 (2): 238–45.e2.
22. Paris J., Facon F., Pascal T., Chrestian M.A., Moulin G., Zanaret M. Preoperative diagnostic values of fine-needle cytology and MRI in parotid gland tumors. Eur Arch Otorhinolaryngol 2005; 262 (1): 27–31.
23. Kato H., Kanematsu M., Watanabe H., Mizuta K., Aoki M. Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components. Neuroradiology 2014; 56 (9): 789–95.
24. Aulino J.M., Kirsch C.F.E., Burns J., Busse P.M., Chakraborty S., Choudhri A.F., et al. ACR Appropriateness Criteria® Neck Mass-Adenopathy. J Am Coll Radiol 2019; 16 (5): S150–60.
25. Inohara H., Akahani S., Yamamoto Y., Hattori K., Tomiyama Y., Tomita Y., et al. The role of fine-needle aspiration cytology and magnetic resonance imaging in the management of parotid mass lesions. Acta Otolaryngol 2008; 128 (10): 1152–8.
26. Alibek S., Zenk J., Bozzato A., Lell M., Grunewald M., Anders K., et al. The Value of Dynamic MRI Studies in Parotid Tumors. Acad Radiol 2007; 14 (6): 701–10.
27. Zheng Y., Xiao Z., Zhang H., She D., Lin X., Lin Y., et al. Differentiation between benign and malignant palatal tumors using conventional MRI: a retrospective analysis of 130 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 125 (4): 343–50.
28. Celebi I., Mahmutoglu A.S., Ucgul A., Ulusay S.M., Basak T., Basak M. Quantitative diffusion-weighted magnetic resonance imaging in the evaluation of parotid gland masses: A study with histopathological correlation. Clin Imaging 2013; 37 (2): 232–8.
29. Ma G., Zhu L.N., Su G.Y., Hu H., Qian W., Bu S.S., et al. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors. Eur Arch Otorhinolaryngol 2018; 275 (8): 2151–7.
30. Zhang Z., Song C., Zhang Y., Wen B., Zhu J., Cheng J. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging. Dentomaxillofac Radiol 2019; 48 (7): 20190100. DOI: 10.1259/DMFR.20190100
31. Thariat J., Vedrine P.O., Orbach D., Marcy P.Y., Badoual C., Butori C., et al. Tumeurs malignes des glandes salivaires chez l’enfant. Bull Cancer 2011; 98 (7): 847–55.
32. Kim M.J., Kim J.S., Roh J.L., Lee J.H., Cho K.J., Choi S.H., et al. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: Preoperative planning for necessity and extent of neck dissection. Ann Surg Oncol 2013; 20 (3): 899–905.
33. Roh J.-L., Hwan Ryu C., Choi S.-H., Seung Kim J., Hyun Lee J., Cho K.-J., et al. Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies. J Nucl Med 2007; 48 (2): 240–6.
34. Cermik T.F., Mavi A., Acikgoz G., Houseni M., Dadparvar S., Alavi A. FDG PET in detecting primary and recurrent malignant salivary gland tumors. Clin Nucl Med 2007; 32 (4): 286–91.
35. Kim B.S., Kim S.J., Pak K. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors. Ann Nucl Med 2016; 30 (5): 346–54.
36. Ashraf A., Shaikh A.S., Kamal F., Sarfraz R., Bukhari M.H. Diagnostic reliability of FNAC for salivary gland swellings: A comparative study. Diagn Cytopathol 2010; 38 (7): 499–504.
37. Carrillo J.F., Ramírez R., Flores L., Ramirez-Ortega M.C., Arrecillas M.D., Ibarra M., et al. Diagnostic accuracy of fine needle aspiration biopsy in preoperative diagnosis of patients with parotid gland masses. J Surg Oncol 2009; 100 (2): 133–8.
38. Eytan D.F., Yin L.X., Maleki Z., Koch W.M., Tufano R.P., Eisele D.W., et al. Utility of preoperative fine needle aspiration in parotid lesions. Laryngoscope 2018; 128 (2): 398–402.
39. Fakhry N., Santini L., Lagier A., Dessi P., Giovanni A. Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. Int J Oral Maxillofac Surg 2014; 43 (7): 802–5.
40. Gudmundsson J.K., Ajan A., Abtahi J. The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients. J Appl Oral Sci 2016; 24 (6): 561–7.
41. Altin F., Alimoglu Y., Acikalin R.M., Yasar H. Is fine needle aspiration biopsy reliable in the diagnosis of parotid tumors? Comparison of preoperative and postoperative results and the factors affecting accuracy. Braz J Otorhinolaryngol 2019; 85 (3): 275–81.
42. Schmidt R.L., Hall B.J., Wilson A.R., Layfield L.J. A Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Parotid Gland Lesions. Am J Clin Pathol 2011; 136 (1): 45–59.
43. Lin A.C., Bhattacharyya N. The Utility of Fine Needle Aspiration in Parotid Malignancy. Otolaryngol Head Neck Surg 2007; 136 (5): 793–8.
44. Baloch Z.W., LiVolsi V.A., Asa S.L., Rosai J., Merino M.J., Randolph G., et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36 (6): 425–37.
45. Schmidt R.L., Hall B.J., Layfield L.J. A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions. Am J Clin Pathol 2011; 136 (4): 516–26.
46. Kim H.J., Kim J.S. Ultrasound-guided core needle biopsy in salivary glands: A meta-analysis. Laryngoscope 2018; 128 (1): 118–25.
47. Cho J., Kim J., Lee J.S., Chee C.G., Kim Y., Choi S.I. Comparison of core needle biopsy and fine-needle aspiration in diagnosis of ma lignant salivary gland neoplasm: Systematic review and meta-analysis. Head Neck 2020; 42 (10): 3041–50.
48. Romano E.B., Wagner J.M., Alleman A.M., Zhao L., Conrad R.D., Krempl G.A. Fine-needle aspiration with selective use of core needle biopsy of major salivary gland tumors. Laryngoscope 2017; 127 (11): 2522–7.
49. Griffith C.C., Pai R.K., Schneider F., Duvvuri U., Ferris R.L., Johnson J.T., et al. Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am J Clin Pathol 2015; 143 (6): 839–53.
50. Wei S., Layfield L.J., LiVolsi V.A., Montone K.T., Baloch Z.W. Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: A comprehensive review. Diagn Cytopathol 2017; 45 (9): 820–7.
51. Rossi E.D., Faquin W.C., Baloch Z., Barkan G.A., Foschini M.P., Pusztaszeri M., et al. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey. Cancer Cytopathol 2017; 125 (10): 757–66.
52. Farahani S.J., Baloch Z. Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: A systematic review and meta-analysis of published literature. Diagn Cytopathol 2019; 47 (2): 67–87.
53. Park W., Bae H., Park M.H., Hwang N.Y., Sohn I., Cho J., et al. Risk of high-grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology. J Oral Pathol Med 2019; 48 (3): 222–31.
54. Johnson D.N., Onenerk M., Krane J.F., Rossi E.D., Baloch Z., Barkan G., et al. Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel. Cancer Cytopathol 2020; 128 (6): 392–402.
55. Jo V.Y., Krane J.F. Ancillary testing in salivary gland cytology: A practical guide. Cancer Cytopathol 2018; 126: 627–42.
56. Bishop J.A., Yonescu R., Batista D.A.S., Westra W.H., Ali S.Z. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol 2013; 121 (5): 228–33.
57. Sun T., Akalin A., Dresser K., Fischer A.H., Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head Neck Pathol 2021; 15 (2): 389–94.
58. Darras N., Mooney K.L., Long S.R. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms. J Am Soc Cytopathol 2019; 8 (3): 157–64.
59. Ryan J.T., El-Naggar A.K., Huh W., Hanna E.Y., Weber R.S., Kupferman M.E. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck 2011; 33 (12): 1769–73.
60. Spiro R.H. Salivary neoplasms: Overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8 (3): 177–84.
61. Fushimi C., Tada Y., Takahashi H., Nagao T., Ojiri H., Masubuchi T., et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol 2018; 29 (4): 979–84.
62. Qureshi S.S., Bhagat M., Singhal N., Tathe N., Kembhavi S., Laskar S., et al. Clinical characteristics and treatment outcomes of primary and recurrent malignancy involving the salivary glands in children. Head Neck 2016; 38 (6): 852–6.
63. Xiao C.C., Zhan K.Y., White-Gilbertson S.J., Day T.A. Predictors of Nodal Metastasis in Parotid Malignancies. Otolaryngol Head Neck Surg 2016; 154 (1): 121–30.
64. Morse E., Fujiwara R.J.T., Judson B., Prasad M.L., Mehra S. Positive surgical margins in parotid malignancies: Institutional variation and survival association. Laryngoscope 2019; 129 (1): 129–37.
65. North L., Stadler M., Massey B., Campbell B., Shukla M., Awan M., et al. Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. Am J Otolaryngol 2019; 40 (6): 102282.
66. Zenga J., Parikh A.S., Emerick K.S., Lin D.T., Faquin W.C., Deschler D.G. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. JAMA Otolaryngol Head Neck Surg 2018; 144 (11): 1011.
67. Stodulski D., Mikaszewski B., Majewska H., Wiśniewski P., Stankiewicz C. Close surgical margin after conservative parotidectomy in early stage low-/intermediate-grade parotid carcinoma: Outcome of watch and wait policy. Oral Oncol 2017; 68: 1–4.
68. Zenga J., Yu Z., Parikh A., Chen J.X., Lin D.T., Emerick K.S., et al. Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. ORL J Otorhinolaryngol Relat Spec 2019; 81 (1): 55–62.
69. Glas A.S., Vermey A., Hollema H., Robinson P.H., Roodenburg J.L.N., Nap R.E., et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients. Head Neck 2001; 23 (4): 311–6.
70. Wang Y.L., Li D.S., Gan H.L., Lu Z.W., Li H., Zhu G.P., et al. Predictive index for lymph node management of major salivary gland cancer. Laryngoscope 2012; 122 (7): 1497–506.
71. Ali S., Palmer F.L., DiLorenzo M., Shah J.P., Patel S.G., Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol 2014; 21 (9): 3042–8.
72. Lim C.M., Gilbert M., Johnson J.T., Kim S. Is level V neck dissection necessary in primary parotid cancer? Laryngoscope 2015; 125 (1): 118–21.
73. Said M.S. Outcomes of Pediatric Patients with Malignancies of the Major Salivary Glands. Yearbook of Pathology and Laboratory Medicine 2011; 2011: 181–2.
74. Wang X., Luo Y., Li M., Yan H., Sun M., Fan T. Management of salivary gland carcinomas-a review. 2017. Available from: www.impactjournals.com/oncotarget.
75. Consensus Formalisé d’Experts.
76. Grant S.R., Grosshans D.R., Bilton S.D., Garcia J.A., Amin M., Chambers M.S., et al. Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics. Radiother Oncol 2015; 116 (2): 309–15.
77. Drilon A., Siena S., Ou S.H.I., Patel M., Ahn M.J., Lee J., et al. Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two phase I trials (ALKA-372-001 and STARTRK-1). Cancer Discov 2017; 7 (4): 400–9.
78. Drilon A., Laetsch T.W., Kummar S., DuBois S.G., Lassen U.N., Demetri G.D., et al. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children. N Engl J Med 2018; 378 (8): 731–9.
Pediatric Hematology/Oncology and Immunopathology. 2023; 22: 177-185
Epithelial malignant tumors of the parotid salivary glands in children and adolescents
https://doi.org/10.24287/1726-1708-2023-22-4-177-185Abstract
The article provides data on epithelial malignant tumors of the parotid salivary glands in children and adolescents. We present a historical background and modern classification proposed by the World Health Organization in 2022. We present the evolution of surgical and non-surgical treatment methods used in pediatric oncology.
References
1. Ethunandan M., Ethunandan A., Macpherson D.W., Conroy B., Pratt C. Parotid neoplasms in children: experience of diagnosis and management in a district general hospital. Int J Oral Maxillofac Surg 2003; 32 (4): 373–7.
2. De Ribeiro K.C.B., Kowalski L.P., Saba L.M.B., De Camargo B. Epithelial salivary glands neoplasms in children and adolescents: a fortyfour-year experience. Med Pediatr Oncol 2002; 39 (6): 594–600.
3. Yoshida E.J., García J., Eisele D.W., Chen A.M. Salivary gland malignancies in children. Int J Pediatr Otorhinolaryngol 2014; 78 (2): 174–8.
4. Zamani M., Grønhøj C., Schmidt Jensen J., von Buchwald C., Charabi B.W., Hjuler T. Survival and characteristics of pediatric salivary gland cancer: A systematic review and meta-analysis. Pediatr Blood Cancer 2019; 66 (3): e27543. DOI: 10.1002/pbc.27543
5. Jensen J.S., Grønhøj C., Garset-Zamani M., Westergaard-Nielsen M., Bjørndal K., Kiss K., et al. Incidence and survival of salivary gland cancer in children and young adults in Denmark: A nation-wide study for the period 1990–2015. Int J Pediatr Otorhinolaryngol 2021; 143: 110637. DOI: 10.1016/j.ijporl.2021.110637
6. Ullah A., Khan J., Waheed A., Karki N.R., Goodbee M., Yasinzai A.Q.K., et al. Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management. Cancers (Basel) 2023; 15 (1): 250. DOI: 10.3390/cancers15010250
7. Geiger J.L., Ismaila N., Beadle B., Caudell J.J., Chau N., Deschler D., et al. Management of Salivary Gland Malignancy: ASCO Guideline. J Clin Oncol 2021; 39 (17): 1909–41.
8. Surun A., Schneider D.T., Ferrari A., Stachowicz-Stencel T., Rascon J., Synakiewicz A., et al. Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations. Pediatr Blood Cancer 2021; 68 (S4). DOI: 10.1002/pbc.29058
9. [Electronic resource] BlueBooksOnline. URL: https://tumourclassification.iarc.who.int/chaptercontent/52/53 (accessed 07.10.2023).
10. Seifert G., Brocheriou C., Cardesa A., Eveson J.W. WHO International Histological Classification of Tumours Tentative Histological Classification of Salivary Gland Tumours. Pathol Res Pract 1990; 186 (5): 555–81.
11. Skálová A., Hyrcza M.D., Leivo I. Update from the 5th Ed. of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands. Head Neck Pathol 2022; 16 (1): 40–53.
12. [Electronic resource] IARC Publications Website – Paediatric Tumours. URL: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Paediatric-Tumours-2023 (accessed 06.10.2023).
13. Aro K., Leivo I., Mäkitie A. Management of salivary gland malignancies in the pediatric population. Curr Opin Otolaryngol Head Neck Surg 2014; 22 (2): 116–20.
14. Sultan I., Rodriguez-Galindo C., Al-Sharabati S., Guzzo M., Casanova M., Ferrari A. Salivary gland carcinomas in children and adolescents: A population-based study, with comparison to adult cases. Head Neck 2011; 33 (10): 1476–81.
15. Laikui L., Hongwei L., Hongbing J., Zhixiu H. Epithelial salivary gland tumors of children and adolescents in west China population: a clinicopathologic study of 79 cases. J Oral Pathol Med 2008; 37 (4): 201–5.
16. Liu B., Liu J.Y., Zhang W.F., Jia J. Pediatric parotid tumors: Clinical review of 24 cases in a Chinese population. Int J Pediatr Otorhinolaryngol 2012; 76 (7): 1007–11.
17. Lennon P., Silvera V.M., Perez-Atayde A., Cunningham M.J., Rahbar R. Disorders and Tumors of the Salivary Glands in Children. Otolaryngol Clin North Am 2015; 48 (1): 153–73.
18. Rzepakowska A., Osuch-Wójcikiewicz E., Sobol M., Cruz R., Sielska-Badurek E., Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Otorhinolaryngol 2017; 274 (8): 3231–40.
19. Zheng M., Plonowska K.A., Strohl M.P., Ryan W.R. Surgeon-performed ultrasound for the assessment of parotid masses. Am J Otolaryngol 2018; 39 (5): 467–71.
20. Mitani Y., Liu B., Rao P.H., Borra V.J., Zafereo M., Weber R.S., et al. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res 2016; 22 (3): 725–33.
21. Liu Y., Li J., Tan Y.R., Xiong P., Zhong L.P. Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119 (2): 238–45.e2.
22. Paris J., Facon F., Pascal T., Chrestian M.A., Moulin G., Zanaret M. Preoperative diagnostic values of fine-needle cytology and MRI in parotid gland tumors. Eur Arch Otorhinolaryngol 2005; 262 (1): 27–31.
23. Kato H., Kanematsu M., Watanabe H., Mizuta K., Aoki M. Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components. Neuroradiology 2014; 56 (9): 789–95.
24. Aulino J.M., Kirsch C.F.E., Burns J., Busse P.M., Chakraborty S., Choudhri A.F., et al. ACR Appropriateness Criteria® Neck Mass-Adenopathy. J Am Coll Radiol 2019; 16 (5): S150–60.
25. Inohara H., Akahani S., Yamamoto Y., Hattori K., Tomiyama Y., Tomita Y., et al. The role of fine-needle aspiration cytology and magnetic resonance imaging in the management of parotid mass lesions. Acta Otolaryngol 2008; 128 (10): 1152–8.
26. Alibek S., Zenk J., Bozzato A., Lell M., Grunewald M., Anders K., et al. The Value of Dynamic MRI Studies in Parotid Tumors. Acad Radiol 2007; 14 (6): 701–10.
27. Zheng Y., Xiao Z., Zhang H., She D., Lin X., Lin Y., et al. Differentiation between benign and malignant palatal tumors using conventional MRI: a retrospective analysis of 130 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 125 (4): 343–50.
28. Celebi I., Mahmutoglu A.S., Ucgul A., Ulusay S.M., Basak T., Basak M. Quantitative diffusion-weighted magnetic resonance imaging in the evaluation of parotid gland masses: A study with histopathological correlation. Clin Imaging 2013; 37 (2): 232–8.
29. Ma G., Zhu L.N., Su G.Y., Hu H., Qian W., Bu S.S., et al. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors. Eur Arch Otorhinolaryngol 2018; 275 (8): 2151–7.
30. Zhang Z., Song C., Zhang Y., Wen B., Zhu J., Cheng J. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging. Dentomaxillofac Radiol 2019; 48 (7): 20190100. DOI: 10.1259/DMFR.20190100
31. Thariat J., Vedrine P.O., Orbach D., Marcy P.Y., Badoual C., Butori C., et al. Tumeurs malignes des glandes salivaires chez l’enfant. Bull Cancer 2011; 98 (7): 847–55.
32. Kim M.J., Kim J.S., Roh J.L., Lee J.H., Cho K.J., Choi S.H., et al. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: Preoperative planning for necessity and extent of neck dissection. Ann Surg Oncol 2013; 20 (3): 899–905.
33. Roh J.-L., Hwan Ryu C., Choi S.-H., Seung Kim J., Hyun Lee J., Cho K.-J., et al. Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies. J Nucl Med 2007; 48 (2): 240–6.
34. Cermik T.F., Mavi A., Acikgoz G., Houseni M., Dadparvar S., Alavi A. FDG PET in detecting primary and recurrent malignant salivary gland tumors. Clin Nucl Med 2007; 32 (4): 286–91.
35. Kim B.S., Kim S.J., Pak K. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors. Ann Nucl Med 2016; 30 (5): 346–54.
36. Ashraf A., Shaikh A.S., Kamal F., Sarfraz R., Bukhari M.H. Diagnostic reliability of FNAC for salivary gland swellings: A comparative study. Diagn Cytopathol 2010; 38 (7): 499–504.
37. Carrillo J.F., Ramírez R., Flores L., Ramirez-Ortega M.C., Arrecillas M.D., Ibarra M., et al. Diagnostic accuracy of fine needle aspiration biopsy in preoperative diagnosis of patients with parotid gland masses. J Surg Oncol 2009; 100 (2): 133–8.
38. Eytan D.F., Yin L.X., Maleki Z., Koch W.M., Tufano R.P., Eisele D.W., et al. Utility of preoperative fine needle aspiration in parotid lesions. Laryngoscope 2018; 128 (2): 398–402.
39. Fakhry N., Santini L., Lagier A., Dessi P., Giovanni A. Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. Int J Oral Maxillofac Surg 2014; 43 (7): 802–5.
40. Gudmundsson J.K., Ajan A., Abtahi J. The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients. J Appl Oral Sci 2016; 24 (6): 561–7.
41. Altin F., Alimoglu Y., Acikalin R.M., Yasar H. Is fine needle aspiration biopsy reliable in the diagnosis of parotid tumors? Comparison of preoperative and postoperative results and the factors affecting accuracy. Braz J Otorhinolaryngol 2019; 85 (3): 275–81.
42. Schmidt R.L., Hall B.J., Wilson A.R., Layfield L.J. A Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Parotid Gland Lesions. Am J Clin Pathol 2011; 136 (1): 45–59.
43. Lin A.C., Bhattacharyya N. The Utility of Fine Needle Aspiration in Parotid Malignancy. Otolaryngol Head Neck Surg 2007; 136 (5): 793–8.
44. Baloch Z.W., LiVolsi V.A., Asa S.L., Rosai J., Merino M.J., Randolph G., et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36 (6): 425–37.
45. Schmidt R.L., Hall B.J., Layfield L.J. A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions. Am J Clin Pathol 2011; 136 (4): 516–26.
46. Kim H.J., Kim J.S. Ultrasound-guided core needle biopsy in salivary glands: A meta-analysis. Laryngoscope 2018; 128 (1): 118–25.
47. Cho J., Kim J., Lee J.S., Chee C.G., Kim Y., Choi S.I. Comparison of core needle biopsy and fine-needle aspiration in diagnosis of ma lignant salivary gland neoplasm: Systematic review and meta-analysis. Head Neck 2020; 42 (10): 3041–50.
48. Romano E.B., Wagner J.M., Alleman A.M., Zhao L., Conrad R.D., Krempl G.A. Fine-needle aspiration with selective use of core needle biopsy of major salivary gland tumors. Laryngoscope 2017; 127 (11): 2522–7.
49. Griffith C.C., Pai R.K., Schneider F., Duvvuri U., Ferris R.L., Johnson J.T., et al. Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am J Clin Pathol 2015; 143 (6): 839–53.
50. Wei S., Layfield L.J., LiVolsi V.A., Montone K.T., Baloch Z.W. Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: A comprehensive review. Diagn Cytopathol 2017; 45 (9): 820–7.
51. Rossi E.D., Faquin W.C., Baloch Z., Barkan G.A., Foschini M.P., Pusztaszeri M., et al. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey. Cancer Cytopathol 2017; 125 (10): 757–66.
52. Farahani S.J., Baloch Z. Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: A systematic review and meta-analysis of published literature. Diagn Cytopathol 2019; 47 (2): 67–87.
53. Park W., Bae H., Park M.H., Hwang N.Y., Sohn I., Cho J., et al. Risk of high-grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology. J Oral Pathol Med 2019; 48 (3): 222–31.
54. Johnson D.N., Onenerk M., Krane J.F., Rossi E.D., Baloch Z., Barkan G., et al. Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel. Cancer Cytopathol 2020; 128 (6): 392–402.
55. Jo V.Y., Krane J.F. Ancillary testing in salivary gland cytology: A practical guide. Cancer Cytopathol 2018; 126: 627–42.
56. Bishop J.A., Yonescu R., Batista D.A.S., Westra W.H., Ali S.Z. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol 2013; 121 (5): 228–33.
57. Sun T., Akalin A., Dresser K., Fischer A.H., Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head Neck Pathol 2021; 15 (2): 389–94.
58. Darras N., Mooney K.L., Long S.R. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms. J Am Soc Cytopathol 2019; 8 (3): 157–64.
59. Ryan J.T., El-Naggar A.K., Huh W., Hanna E.Y., Weber R.S., Kupferman M.E. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck 2011; 33 (12): 1769–73.
60. Spiro R.H. Salivary neoplasms: Overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8 (3): 177–84.
61. Fushimi C., Tada Y., Takahashi H., Nagao T., Ojiri H., Masubuchi T., et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol 2018; 29 (4): 979–84.
62. Qureshi S.S., Bhagat M., Singhal N., Tathe N., Kembhavi S., Laskar S., et al. Clinical characteristics and treatment outcomes of primary and recurrent malignancy involving the salivary glands in children. Head Neck 2016; 38 (6): 852–6.
63. Xiao C.C., Zhan K.Y., White-Gilbertson S.J., Day T.A. Predictors of Nodal Metastasis in Parotid Malignancies. Otolaryngol Head Neck Surg 2016; 154 (1): 121–30.
64. Morse E., Fujiwara R.J.T., Judson B., Prasad M.L., Mehra S. Positive surgical margins in parotid malignancies: Institutional variation and survival association. Laryngoscope 2019; 129 (1): 129–37.
65. North L., Stadler M., Massey B., Campbell B., Shukla M., Awan M., et al. Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. Am J Otolaryngol 2019; 40 (6): 102282.
66. Zenga J., Parikh A.S., Emerick K.S., Lin D.T., Faquin W.C., Deschler D.G. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. JAMA Otolaryngol Head Neck Surg 2018; 144 (11): 1011.
67. Stodulski D., Mikaszewski B., Majewska H., Wiśniewski P., Stankiewicz C. Close surgical margin after conservative parotidectomy in early stage low-/intermediate-grade parotid carcinoma: Outcome of watch and wait policy. Oral Oncol 2017; 68: 1–4.
68. Zenga J., Yu Z., Parikh A., Chen J.X., Lin D.T., Emerick K.S., et al. Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. ORL J Otorhinolaryngol Relat Spec 2019; 81 (1): 55–62.
69. Glas A.S., Vermey A., Hollema H., Robinson P.H., Roodenburg J.L.N., Nap R.E., et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients. Head Neck 2001; 23 (4): 311–6.
70. Wang Y.L., Li D.S., Gan H.L., Lu Z.W., Li H., Zhu G.P., et al. Predictive index for lymph node management of major salivary gland cancer. Laryngoscope 2012; 122 (7): 1497–506.
71. Ali S., Palmer F.L., DiLorenzo M., Shah J.P., Patel S.G., Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol 2014; 21 (9): 3042–8.
72. Lim C.M., Gilbert M., Johnson J.T., Kim S. Is level V neck dissection necessary in primary parotid cancer? Laryngoscope 2015; 125 (1): 118–21.
73. Said M.S. Outcomes of Pediatric Patients with Malignancies of the Major Salivary Glands. Yearbook of Pathology and Laboratory Medicine 2011; 2011: 181–2.
74. Wang X., Luo Y., Li M., Yan H., Sun M., Fan T. Management of salivary gland carcinomas-a review. 2017. Available from: www.impactjournals.com/oncotarget.
75. Consensus Formalisé d’Experts.
76. Grant S.R., Grosshans D.R., Bilton S.D., Garcia J.A., Amin M., Chambers M.S., et al. Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics. Radiother Oncol 2015; 116 (2): 309–15.
77. Drilon A., Siena S., Ou S.H.I., Patel M., Ahn M.J., Lee J., et al. Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two phase I trials (ALKA-372-001 and STARTRK-1). Cancer Discov 2017; 7 (4): 400–9.
78. Drilon A., Laetsch T.W., Kummar S., DuBois S.G., Lassen U.N., Demetri G.D., et al. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children. N Engl J Med 2018; 378 (8): 731–9.
